Skip to main content
. 2018 May 7;5:129. doi: 10.3389/fmed.2018.00129

Table 1.

Overview of pathogen inactivation (PI) treatment options to obtain pathogen-reduced platelet products.

Product treatment Storage solution PI system

INTERCEPT MIRASOL THERAFLEX
AP/PC Plasma + +
PAS + + +
PRPC or BC/PC Plasma + +
PAS + + +
WB (prior to PRPC or BC/PC production) Plasma +
PAS +

AP/PC, apheresis platelet concentrates; PRPC, platelet-rich plasma concentrate; BC/PC, buffy-coat-derived platelet concentrate; WB, whole blood; PAS, platelet additive solution.